Global
# |
Name |
Net Income |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 14.85 B
|
Dec. 31, 2023 | USD 98.71 | -0.26% |
|
Switzerland |
|
2 |
USD 14.68 B
|
Sept. 29, 2024 | USD 144.75 | 0.19% |
|
United States |
|
3 |
USD 14.32 B
|
Sept. 30, 2024 | USD 543.74 | 0.48% |
|
United States |
|
4 |
USD 13.66 B
|
Dec. 31, 2023 | USD 310.22 | 0.71% |
|
Switzerland |
|
5 |
USD 12.39 B
|
Dec. 31, 2023 | USD 81.56 | -2.90% |
|
Denmark |
|
6 |
USD 12.15 B
|
Sept. 30, 2024 | USD 99.65 | -1.32% |
|
United States |
|
7 |
USD 8.37 B
|
Sept. 30, 2024 | USD 744.91 | -6.59% |
|
United States |
|
8 |
USD 6.27 B
|
Dec. 31, 2023 | USD 15.79 | -2.73% |
|
United Kingdom |
|
9 |
USD 6.14 B
|
Sept. 28, 2024 | USD 556.99 | 0.27% |
|
United States |
|
10 |
USD 5.96 B
|
Dec. 31, 2023 | USD 96.09 | -1.23% |
|
France |
|
11 |
USD 5.96 B
|
Dec. 31, 2023 | USD 129.77 | -1.69% |
|
United Kingdom |
|
12 |
USD 5.77 B
|
Sept. 30, 2024 | USD 113.02 | -0.15% |
|
United States |
|
13 |
USD 5.12 B
|
Sept. 30, 2024 | USD 175.55 | -0.67% |
|
United States |
|
14 |
USD 5.02 B
|
Sept. 30, 2024 | USD 51.57 | 0.10% |
|
United States |
|
15 |
USD 4.65 B
|
Sept. 30, 2024 | USD 690.87 | -3.63% |
|
United States |
|
16 |
USD 4.35 B
|
March 31, 2024 | USD 10.94 | 1.86% |
|
United Kingdom |
|
17 |
USD 4.29 B
|
Oct. 25, 2024 | USD 85.25 | 4.23% |
|
Ireland |
|
18 |
USD 4.26 B
|
Sept. 29, 2024 | USD 26.41 | -1.46% |
|
United States |
|
19 |
USD 4.23 B
|
Sept. 30, 2024 | USD 267.10 | -1.14% |
|
United States |
|
20 |
USD 4.16 B
|
Sept. 30, 2024 | USD 71.04 | -0.07% |
|
United States |
|
21 |
USD 3.89 B
|
Sept. 27, 2024 | USD 237.62 | -0.94% |
|
United States |
|
22 |
USD 3.42 B
|
Dec. 31, 2023 | USD 24.69 | -1.27% |
|
Japan |
|
23 |
USD 3.13 B
|
Sept. 30, 2024 | USD 127.63 | -1.27% |
|
United States |
|
24 |
USD 3.12 B
|
Dec. 31, 2023 | USD 145.16 | 0.75% |
|
Germany |
|
25 |
USD 3.07 B
|
Sept. 30, 2024 | USD 63.40 | -0.47% |
|
United States |
|
26 |
USD 3.04 B
|
Sept. 30, 2024 | USD 285.03 | 0.91% |
|
United States |
|
27 |
USD 2.87 B
|
Sept. 30, 2024 | USD 87.67 | 0.65% |
|
United States |
|
28 |
USD 2.64 B
|
June 30, 2024 | USD 173.13 | 0.11% |
|
Australia |
|
29 |
USD 2.54 B
|
Sept. 30, 2024 | USD 593.73 | 1.48% |
|
United States |
|
30 |
USD 2.43 B
|
Sept. 30, 2024 | USD 164.41 | -1.15% |
|
United States |
|
31 |
USD 2.31 B
|
Dec. 31, 2023 | USD 43.03 | 0.75% |
|
Japan |
|
32 |
USD 2.27 B
|
Dec. 31, 2023 | USD 45.94 | 0.03% |
|
United Kingdom |
|
33 |
USD 2.24 B
|
Sept. 30, 2024 | USD 538.88 | -0.16% |
|
United States |
|
34 |
USD 2.16 B
|
Sept. 30, 2024 | USD 52.62 | 1.24% |
|
Germany |
|
35 |
USD 2.09 B
|
Dec. 31, 2023 | USD 59.37 | -0.51% |
|
United Kingdom |
|
36 |
USD 1.79 B
|
Sept. 30, 2024 | USD 95.65 | 1.10% |
|
United States |
|
37 |
USD 1.73 B
|
Sept. 30, 2024 | USD 235.80 | -0.17% |
|
United States |
|
38 |
USD 1.68 B
|
Sept. 30, 2024 | USD 84.13 | -1.40% |
|
United States |
|
39 |
USD 1.64 B
|
Sept. 30, 2024 | USD 12.74 | -6.60% |
|
United States |
|
40 |
USD 1.63 B
|
Dec. 31, 2023 | USD 32.18 | 1.97% |
|
China |
|
41 |
USD 1.62 B
|
Sept. 30, 2024 | USD 143.06 | -4.74% |
|
United States |
|
42 |
USD 1.61 B
|
March 31, 2024 | USD 20.70 | -1.48% |
|
Japan |
|
43 |
USD 1.60 B
|
March 31, 2024 | USD 14.83 | 0.94% |
|
Japan |
|
44 |
USD 1.58 B
|
Dec. 31, 2023 | USD 122.81 | -2.58% |
|
Canada |
|
45 |
USD 1.51 B
|
Sept. 30, 2024 | USD 240.05 | 1.68% |
|
United States |
|
46 |
USD 1.41 B
|
Sept. 30, 2024 | USD 197.96 | -3.26% |
|
United States |
|
47 |
USD 1.36 B
|
Sept. 30, 2024 | USD 282.63 | -1.65% |
|
United States |
|
48 |
USD 1.35 B
|
Dec. 31, 2023 | USD 6.95 | 4.11% |
|
China |
|
49 |
USD 1.33 B
|
Dec. 31, 2023 | USD 4.48 | -0.21% |
|
United Kingdom |
|
50 |
USD 1.33 B
|
March 31, 2024 | USD 26.30 | 0.47% |
|
Japan |
The Pharmaceuticals company with the highest Net Income is Novartis AG (Swiss Stock Exchange: NOVN.SW) at USD 14.85 B.
The Pharmaceuticals company with the lowest Net Income is Inovio Pharmaceuticals, Inc. (NasdaqCM: INO) at USD -25.25 B.
The top 10 Pharmaceuticals companies the Global by Net Income are Novartis AG, Johnson & Johnson, UnitedHealth Group Incorporated, Roche Holding AG, Novo Nordisk A/S, Merck & Co., Inc., Eli Lilly and Company, GSK plc, Thermo Fisher Scientific Inc. and Sanofi.
The bottom 10 Pharmaceuticals companies by Net Income are Inovio Pharmaceuticals, Inc., Nutex Health, Inc., Bristol-Myers Squibb Company, Bayer Aktiengesellschaft, ZyVersa Therapeutics, Inc., Moderna, Inc., Sumitomo Pharma Co., Ltd., GRAIL, LLC, Albemarle Corporation and QuidelOrtho Corporation.